EW vs SNOA · P/E 47, rev $3.39B vs rev $19.5M
Edwards Lifesciences Corp (EW) versus Sonoma Pharmaceuticals Inc (SNOA) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Sonoma Pharmaceuticals Inc (SNOA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported SNOA revenue for 2026-03-31 was $19.5M. Net income was -$3.2M. Revenue was up 36.7% from 2025-03-31 to 2026-03-31. SNOA currently screens at market cap $4.9M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. SNOA currently screens at market cap $4.9M.
Not investment advice. Open the EW and SNOA stock pages for the full models.
Not investment advice.